DocDollars

Cochlear Americas

CO · United States · Reporting entity ID 100000005734

Total reported 2019–2025
$22.1M
#299 of 2,960 reporting companies — 0% of all reported industry payments
$2.56M in general payments across 9,137 records, plus $19.5M in research funding across 2,340 records.

How it breaks down

General payments $2,557,465
Research funding $19,505,678

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Cochlear Americas reported $22.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #299 of 2,960 reporting companies. 88% of that was research funding and 12% general payments such as consulting, speaking, food and travel. 9,137 general payment records and 2,340 research records were filed.

Common questions about Cochlear Americas

How much has Cochlear Americas paid US doctors?

Cochlear Americas reported $22,063,142 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,557,465 in general payments, $19,505,678 in research funding.

How does Cochlear Americas rank among drug and device companies?

It ranks #299 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Cochlear Americas mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.